SCHEMBL6474253

SCHEMBL6474253

O=C(O)COc1ccc(C(=O)N2CCCCC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.70
KDM4E B2RXH2 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
ALDH1A1 P00352 6/20 0.67
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
HSD17B10 Q99714 1/20 0.61
MAOB P27338 1/20 0.61
AOC3 Q16853 1/20 0.61
MAPT P10636 2/20 0.60
RAB9A P51151 2/20 0.60
NPC1 O15118 1/20 0.60
HRH3 Q9Y5N1 1/20 0.57
ITGB3 P05106 1/20 0.55
ITGA2B P08514 1/20 0.55
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27382331 0.85 SIGMAR1 (0.59) HPGDKDM4EL3MBTL1ALDH1A1MEN1
Hydrochloric Acid SCHEMBL11710564 0.84 ITGB3 (0.54) HPGDKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL7864765 0.82 MEN1 (0.60) HPGDALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL15420889 0.81 NPC1 (0.76) HPGDKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL8463058 0.79 L3MBTL3 (0.57) HPGDKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL27479149 0.79 HPGD (1.00) HPGDL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL7132525 0.79 HPGD (1.00) HPGDL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL16774524 0.79 HPGD (0.67) HPGDKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL25667509 0.79 HPGD (0.67) HPGDKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL21987030 0.79 ITGB3 (0.62) ALDH1A1MEN1KMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020109233-A2 TRMT2A INHIBITORS FOR USE IN THE TREATMENT OF POLYGLUTAMINE DISEASES FORSCHUNGSZENTRUM JÜLICH GMBH FACHBEREICH PATENTE (R-P) (DE) 2020-06-04 WO disclosed
EP-3659593-A1 TRMT2A INHIBITORS FOR USE IN THE TREATMENT OF POLYGLUTAMINE DISEASES Forschungszentrum Jülich GmbH/ Abteilung RP-PT (DE) 2020-06-03 EP disclosed
US-6867192-B1 Compounds useful in the treatment of inflammatory diseases GLAXO GROUP LIMITED (GB) 2005-03-15 US disclosed
EP-1140837-B1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LTD (GB) 2004-08-18 EP disclosed
EP-1140837-A1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2001-10-10 EP disclosed
WO-2000037444-A1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2000-06-29 WO disclosed